Radioisotopic Bone Scintigraphy with the Gamma Camera in the Investigation of Prostatic Cancer

Shearer, R. J.; Constable, A. R.; Girling, M.; Hendry, W. F.; Fergusson, J. D.
May 1974
British Medical Journal;5/18/1974, Vol. 2 Issue 5915, p362
Academic Journal
No abstract available.


Related Articles

  • Metastatic superscan on 99mTc-MDP bone scintigraphy in a case of carcinoma colon: Common finding but rare etiology. Chakraborty, Partha Sarathi; Sharma, Punit; Karunanithi, Sellam; Bal, Chandrasekhar; Kumar, Rakesh // Indian Journal of Nuclear Medicine;Jul-Sep2014, Vol. 29 Issue 3, p158 

    Bone scintigraphy in which there is excessive skeletal radioisotope uptake in relation to soft tissues along with absent or faint activity in the genitourinary tract is known as a 'superscan'. Prostate cancer is the most common malignancy associated with superscan along with others such as lung...

  • Cytogen and Dowpharma to Develop Targeted Anticancer Product. Chiarello, Kaylynn // Pharmaceutical Technology;Jun2005, Vol. 29 Issue 6, p20 

    This article reports that Cytogen Corp. and Dowpharma, a business unit of Dow Chemical Co. have joined forces to develop a new, targeted therapy to treat prostate and other cancers. This monoclonal antibody targets prostate-specific membrane antigen, a protein often expressed by the most...

  • 99mTc-MDP bone scintigraphy and 18 F-FDG positron emission tomography in lung and prostate cancer patients: different affinity between lytic and sclerotic bone metastases. Garcia, J. R.; Simo, M.; Perez, G.; Soler, M.; Lopez, S.; Setoain, X.; Lomeña, F. // European Journal of Nuclear Medicine & Molecular Imaging;2003, Vol. 30 Issue 12, p1714 

    Presents images depicting bone scintigraphy and positron emission tomography in lung and prostate cancer.

  • Bone scintigraphy predicts the risk of spinal cord compression in hormone-refractory prostate cancer. Soerdjbahe-Maikoe, Vidija; Pelger, Rob C. M.; Lycklama à Nijeholt, Guus A. B.; Arndt, Jan-Willem; Zwinderman, Aeilko H.; Bril, Herman; Papapoulos, Socrates E.; Hamdy, Neveen A. T. // European Journal of Nuclear Medicine & Molecular Imaging;2004, Vol. 31 Issue 7, p958 

    In prostate cancer, confirmation of metastatic involvement of the skeleton has traditionally been achieved by bone scintigraphy, although the widespread availability of prostate-specific antigen (PSA) measurements has tended to eliminate the need for this investigation. The potential of bone...

  • Can 16-detector multislice CT exclude skeletal lesions during tumour staging? Implications for the cancer patient. Groves, Ashley M.; Beadsmoore, Clare J.; Cheow, Heok K.; Balan, Kottekkattu K.; Courtney, Helen M.; Kaptoge, Stephen; Win, Thida; Harish, Srinivasan; Bearcroft, Philip W. P.; Dixon, Adrian K. // European Radiology;May2006, Vol. 16 Issue 5, p1066 

    Current imaging guidelines recommend that many cancer patients undergo soft-tissue staging by computed tomography (CT) whilst the bones are imaged by skeletal scintigraphy (bone scan). New CT technology has now made it feasible, for the first time, to perform a detailed whole-body skeletal CT....

  • Premature conclusions may harm good ideas. Staudenherz, Anton; Sinzinger, Helmut // European Journal of Nuclear Medicine & Molecular Imaging;May2005, Vol. 32 Issue 5, p625 

    Presents a letter to the editor concerning the results of a study on the value of qualitative assessment of bone scintigraphy in patients with hormone-refractory prostate cancer.

  • Reply to the letter 'Choline PET/CT compared with bone scintigraphy in the detection of bone metastases in prostate cancer patients'. Picchio, M.; Mapelli, P.; Fallanca, F.; Messa, C. // European Journal of Nuclear Medicine & Molecular Imaging;May2012, Vol. 39 Issue 5, p912 

    A response by M. Picchio and colleagues to a letter to the editor "[11C]Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: comparison with bone scintigraphy" is presented.

  • Distribution Features of Skeletal Metastases: A Comparative Study between Pulmonary and Prostate Cancers. Wang, Changyin; Shen, Ying; Zhu, Shaobo // PLoS ONE;11/23/2015, Vol. 10 Issue 11, p1 

    Bone scintigraphies are widely applied for detecting bone metastases. The aim of this study was to investigate distribution features of bone metastases in pulmonary and prostate cancers. Bone scintigraphies were performed in 460 patients with pulmonary cancer and 144 patients with prostate...

  • An Unusual Case of Extraosseous Accumulation of Bone Scan Tracer in a Renal Calculus - Demonstration by SPECT-CT. Joshi, Prathamesh Vijay; Lele, Vikram; Gandhi, Rozil // Journal of Clinical Imaging Science;Jan-Mar2012, Vol. 2 Issue 1, Special section p1 

    Extraosseous localization of radioisotope, used in bone scan, in a variety of physiological and pathological conditions is a well-known phenomenon. The causes of extraosseous accumulation of bone-seeking radiotracers should be kept in mind when bone-imaging studies are reviewed to avoid...

  • Nuklearmedizinische Diagnostik von Knochenmetastasen. Strobel, K. // Praxis (16618157);11/4/2009, Vol. 98 Issue 22, p1293 

    Conventional bone scintigraphy is still the standard investigation for the detection of bone metastases, especially in breast and prostate cancer. In unclear scintigraphic uptakes in the appendicular skeleton conventional x-rays are problem solving in most of the cases. In unclear uptakes in the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics